久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Celleron picks up discarded cancer drug from Roche pharmatimes
    August 14, 2020
    Oxford, UK-based Celleron Therapeutics has signed a licensing agreement with Roche for exclusive rights to emactuzumab, a monoclonal antibody and tumour microenvironment modulator.
  • Celleron licenses cancer drug emactuzumab from Roche pharmaceutical-technology
    August 14, 2020
    UK-based Celleron Therapeutics has entered an exclusive licensing agreement with Roche for global rights to the clinical development, manufacturing and commercialisation of cancer drug, emactuzumab.
PharmaSources Customer Service